MedPath

Squalamine

Generic Name
Squalamine
Drug Type
Small Molecule
Chemical Formula
C34H65N3O5S
CAS Number
148717-90-2
Unique Ingredient Identifier
F8PO54Z4V7

Overview

No overview information available.

Indication

Investigated for use/treatment in ovarian cancer, lung cancer, and macular degeneration.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2016/04/05
Phase 3
UNKNOWN
2015/11/25
Phase 1
Completed
2015/07/30
Phase 2
Withdrawn
2015/01/29
Phase 2
Withdrawn
Starr Muscle
2013/01/16
Phase 2
Completed
Elman Retina Group
2012/09/05
Phase 2
Completed
2005/10/27
Phase 2
Withdrawn
2005/08/31
Phase 3
Terminated
Genaera Corporation
2004/02/04
Phase 2
UNKNOWN

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath